中文名稱

13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard (50 mg)

英文名字

13,14-dihydro-15-keto PGE2, 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard, 9,15-dioxo-11

供應商

Cayman

產(chǎn)品貨號

10007214-50

產(chǎn)品報價

￥28910/50 mg

產(chǎn)品說明書

點擊查看

購買方式

產(chǎn)品新聞

背景資料

13,14-dihydro Prostaglandin E2 -13,14-dh-15-keto PGE2) is the primary metabolite of PGE2 in plasma. Endogenous or infused PGE2 is rapidly metabolized by the enzymes 15-hydroxy PGDH and 15-oxo-prostaglandin .DELTA.13-reductase to form 13,14-dh-15-keto PGE2. 13,14-dh-15-keto PGE2 accumulates to detectable levels; plasma levels in humans are between 10-100 pg/ml. It undergoes further metabolism and chemical decomposition, giving it a relatively short half-life. In dogs, the plasma half-life of 13,14-dh-15-keto PGE2 is about 9 minutes. In humans the metabolite has a similar short half-life, making it a poor choice of analytes for assays designed to measure total PGE2 biosynthesis.

產(chǎn)品描述

產(chǎn)品形式

保存建議

-20

其他

Cayman Chemical

注意

該頁面的中文產(chǎn)品信息的翻譯，僅供參考。準確的產(chǎn)品信息請以廠家的英文說明書為準。下單前，請瀏覽說明書確認。

分享到：